Design, Synthesis, and Evaluation of Orally Bioavailable Quinoline–Indole Derivatives as Innovative Multitarget-Directed Ligands: Promotion of Cell Proliferation in the Adult Murine Hippocampus for the Treatment of Alzheimer’s Disease

Alzheimer’s disease: Clinical trials and drug development

Mangialasche, F., Solomon, A., Winblad, B., Mecocci, P., & Kivipelto, M. (2010) · The Lancet Neurology · doi:10.1016/s1474-4422(10)70119-8 · Cited by 1,217 · see citing works

High throughput artificial membrane permeability assay for blood–brain barrier

Di, L., Kerns, E. H., Fan, K., McConnell, O. J., & Carter, G. T. (2003) · European Journal of Medicinal Chemistry · doi:10.1016/s0223-5234(03)00012-6 · Cited by 1,195 · see citing works

Untitled work

(2016) · London School of Economics and Political Science Research Online (London School of Economics and Political Science) · Cited by 874 · see citing works

Rapid Restoration of Cognition in Alzheimer's Transgenic Mice with 8-Hydroxy Quinoline Analogs Is Associated with Decreased Interstitial Aβ

Adlard, P. A., Cherny, R. A., Finkelstein, D. I., Gautier, E., Robb, E., Cortes, M., Volitakis, I., Liu, X., Smith, J. P., Perez, K., et al. (2008) · Neuron · doi:10.1016/j.neuron.2008.06.018 · Cited by 672 · see citing works

Fluoxetine targets early progenitor cells in the adult brain

Encinas, J. M., Vaahtokari, A., & Enikolopov, G. (2006) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0601992103 · Cited by 637 · see citing works

CNS Drug Design: Balancing Physicochemical Properties for Optimal Brain Exposure

Ranković, Z. (2014) · Journal of Medicinal Chemistry · doi:10.1021/jm501535r · Cited by 582 · see citing works

A regenerative approach to the treatment of multiple sclerosis

Deshmukh, V. A., Tardif, V., Lyssiotis, C. A., Green, C. C., Kerman, B., Kim, H. J., Padmanabhan, K., Swoboda, J. G., Ahmad, I., Kondo, T., et al. (2013) · Nature · doi:10.1038/nature12647 · Cited by 522 · see citing works

Biological metals and metal-targeting compounds in major neurodegenerative diseases

Barnham, K. J., & Bush, A. I. (2014) · Chem. Soc. Rev. · doi:10.1039/c4cs00138a · Cited by 497 · see citing works

High-Throughput Permeability pH Profile and High-Throughput Alkane/Water logPwith Artificial Membranes

Wohnsland, F., & Faller, B. (2001) · Journal of Medicinal Chemistry · doi:10.1021/jm001020e · Cited by 496 · see citing works

PBT2 Rapidly Improves Cognition in Alzheimer's Disease: Additional Phase II Analyses

Faux, N. G., Ritchie, C. W., Gunn, A. P., Rembach, A., Tsatsanis, A., Bedő, J., Harrison, J., Lannfelt, L., Blennow, K., Zetterberg, H., et al. (2010) · Journal of Alzheimer s Disease · doi:10.3233/jad-2010-1390 · Cited by 406 · see citing works

Discovery of a Proneurogenic, Neuroprotective Chemical

Pieper, A. A., Xie, S., Capota, E., Estill, S. J., Zhong, J., Long, J. M., Becker, G. L., Huntington, P. J., Goldman, S. E., Shen, C.-H., et al. (2010) · Cell · doi:10.1016/j.cell.2010.06.018 · Cited by 350 · see citing works

Design, synthesis, and evaluation of novel bifunctional iron-chelators as potential agents for neuroprotection in Alzheimer’s, Parkinson’s, and other neurodegenerative diseases

Zheng, H., Weiner, L. M., Bar-Am, O., Epsztejn, S., Cabantchik, Z. I., Warshawsky, A., Youdim, M. B. H., & Fridkin, M. (2005) · Bioorganic & Medicinal Chemistry · doi:10.1016/j.bmc.2004.10.037 · Cited by 278 · see citing works

Allopregnanolone reverses neurogenic and cognitive deficits in mouse model of Alzheimer's disease

Wang, J. M., Singh, C., Liu, L., Irwin, R. W., Chen, S., Chung, E. J., Thompson, R. F., & Brinton, R. D. (2010) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1001422107 · Cited by 263 · see citing works

Novel Tacrine−Melatonin Hybrids as Dual-Acting Drugs for Alzheimer Disease, with Improved Acetylcholinesterase Inhibitory and Antioxidant Properties

Rodrı́guez-Franco, M. I., Fernández‐Bachiller, M. I., Pérez, C., Hernández‐Ledesma, B., & Bartolomé, B. (2005) · Journal of Medicinal Chemistry · doi:10.1021/jm050746d · Cited by 250 · see citing works

P7C3 Neuroprotective Chemicals Function by Activating the Rate-Limiting Enzyme in NAD Salvage

Wang, G., Han, T., Nijhawan, D., Theodoropoulos, P., Naidoo, J., Yadavalli, S., Mirzaei, H., Pieper, A. A., Ready, J. M., & McKnight, S. L. (2014) · Cell · doi:10.1016/j.cell.2014.07.040 · Cited by 243 · see citing works

Melatonin Modulates Cell Survival of New Neurons in the Hippocampus of Adult Mice

Ramírez-Rodríguez, G. B., Klempin, F., Babu, H., Benítez‐King, G., & Kempermann, G. (2009) · Neuropsychopharmacology · doi:10.1038/npp.2009.46 · Cited by 229 · see citing works

Regulation of Copper and Iron Homeostasis by Metal Chelators: A Possible Chemotherapy for Alzheimer’s Disease

Robert, A., Liu, Y., Nguyen, M., & Meunier, B. (2015) · Accounts of Chemical Research · doi:10.1021/acs.accounts.5b00119 · Cited by 212 · see citing works

Structural and functional rejuvenation of the aged brain by an approved anti-asthmatic drug

Marschallinger, J., Schäffner, I., Klein, B., Gelfert, R., Rivera, F. J., Illes, S., Grassner, L., Janssen, M., Rotheneichner, P., Schmuckermair, C., et al. (2015) · Nature Communications · doi:10.1038/ncomms9466 · Cited by 193 · see citing works

Inhibition of Acetylcholinesterase, β-Amyloid Aggregation, and NMDA Receptors in Alzheimer’s Disease: A Promising Direction for the Multi-target-Directed Ligands Gold Rush

Rosini, M., Simoni, E., Bartolini, M., Cavalli, A., Ceccarini, L., Pascu, N., McClymont, D. W., Tarozzi, A., Bolognesi, M. L., Minarini, A., et al. (2008) · Journal of Medicinal Chemistry · doi:10.1021/jm800577j · Cited by 186 · see citing works

Pyrano[3,2-c]quinoline−6-Chlorotacrine Hybrids as a Novel Family of Acetylcholinesterase- and β-Amyloid-Directed Anti-Alzheimer Compounds

Camps, P., Formosa, X., Galdeano, C., Muñoz‐Torrero, D., Ramírez, L., Gómez, E., Isambert, N., Lavilla, R., Badı́a, A., Clos, M. V., et al. (2009) · Journal of Medicinal Chemistry · doi:10.1021/jm900859q · Cited by 174 · see citing works

The Ongoing Search for Small Molecules to Study Metal-Associated Amyloid-β Species in Alzheimer’s Disease

Savelieff, M. G., DeToma, A. S., Derrick, J. S., & Lim, M. H. (2014) · Accounts of Chemical Research · doi:10.1021/ar500152x · Cited by 174 · see citing works

Development of Proneurogenic, Neuroprotective Small Molecules

MacMillan, K. S., Naidoo, J., Liang, J., Melito, L. M., Williams, N. S., Morlock, L., Huntington, P. J., Estill, S. J., Longgood, J. C., Becker, G. L., et al. (2011) · Journal of the American Chemical Society · doi:10.1021/ja108211m · Cited by 170 · see citing works

Synthesis and Multitarget Biological Profiling of a Novel Family of Rhein Derivatives As Disease-Modifying Anti-Alzheimer Agents

Viayna, E., Sola, I., Bartolini, M., Simone, A. D., Tapia‐Rojas, C., Serrano, F. G., Sabaté, R., Juárez‐Jiménez, J., Pérez, B., Luque, F. J., et al. (2014) · Journal of Medicinal Chemistry · doi:10.1021/jm401824w · Cited by 156 · see citing works

Specific inhibition of CBP/β-catenin interaction rescues defects in neuronal differentiation caused by a presenilin-1 mutation

Teo, J.-L., Ma, H., Nguyen, C., Lam, C., & Kahn, M. (2005) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0504600102 · Cited by 151 · see citing works

Neuroprotective efficacy of aminopropyl carbazoles in a mouse model of Parkinson disease

Jesús‐Cortés, H. D., Xu, P., Drawbridge, J., Estill, S. J., Huntington, P. J., Tran, S., Britt, J. K., Tesla, R., Morlock, L., Naidoo, J., et al. (2012) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1213956109 · Cited by 130 · see citing works

Neuroprotective efficacy of aminopropyl carbazoles in a mouse model of amyotrophic lateral sclerosis

Tesla, R., Wolf, H. P., Xu, P., Drawbridge, J., Estill, S. J., Huntington, P., McDaniel, L., Knobbe, W., Burket, A., Tran, S., et al. (2012) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1213960109 · Cited by 129 · see citing works

Design, Synthesis, and Evaluation of Orally Available Clioquinol-Moracin M Hybrids as Multitarget-Directed Ligands for Cognitive Improvement in a Rat Model of Neurodegeneration in Alzheimer’s Disease

Wang, Z., Wang, Y., Wang, B., Li, W., Huang, L., & Li, X. (2015) · Journal of Medicinal Chemistry · doi:10.1021/acs.jmedchem.5b01222 · Cited by 120 · see citing works

Alzheimer’s Disease: Pathophysiology and Applications of Magnetic Nanoparticles as MRI Theranostic Agents

Amiri, H., Saeidi, K., Borhani, P., Manafirad, A., Ghavami, M., & Zerbi, V. (2013) · ACS Chemical Neuroscience · doi:10.1021/cn4001582 · Cited by 114 · see citing works

Quinazolin-4-one Derivatives as Selective Histone Deacetylase-6 Inhibitors for the Treatment of Alzheimer’s Disease

Yu, C., Chang, P., Hsin, L., & Chern, J. (2013) · Journal of Medicinal Chemistry · doi:10.1021/jm400564j · Cited by 106 · see citing works

Structure-Based Design and Optimization of Multitarget-Directed 2H-Chromen-2-one Derivatives as Potent Inhibitors of Monoamine Oxidase B and Cholinesterases

Farina, R., Pisani, L., Catto, M., Nicolotti, O., Gadaleta, D., Denora, N., Soto‐Otero, R., Méndez‐Álvarez, E., Passos, C. D. S., Muncipinto, G., et al. (2015) · Journal of Medicinal Chemistry · doi:10.1021/acs.jmedchem.5b00599 · Cited by 100 · see citing works

P7C3 and an unbiased approach to drug discovery for neurodegenerative diseases

Pieper, A. A., McKnight, S. L., & Ready, J. M. (2014) · Chemical Society Reviews · doi:10.1039/c3cs60448a · Cited by 99 · see citing works

Multi-target-directed phenol–triazole ligands as therapeutic agents for Alzheimer's disease

Jones, M. R., Mathieu, É., Dyrager, C., Faissner, S., Vaillancourt, Z., Korshavn, K. J., Lim, M. H., Ramamoorthy, A., Yong, V. W., Tsutsui, S., et al. (2017) · Chemical Science · doi:10.1039/c7sc01269a · Cited by 96 · see citing works

Design, synthesis and pharmacological evaluation of hybrid molecules out of quinazolinimines and lipoic acid lead to highly potent and selective butyrylcholinesterase inhibitors with antioxidant properties

Decker, M. W., Kraus, B., & Heilmann, J. (2008) · Bioorganic & Medicinal Chemistry · doi:10.1016/j.bmc.2008.02.083 · Cited by 94 · see citing works

New Melatonin–N,N-Dibenzyl(N-methyl)amine Hybrids: Potent Neurogenic Agents with Antioxidant, Cholinergic, and Neuroprotective Properties as Innovative Drugs for Alzheimer’s Disease

López-Iglesias, B., Pérez, C., Morales-Garcia, J. A., Alonso‐Gil, S., Pérez‐Castillo, A., Romero, A., López, M. G., Villarroya, M., Conde, S., & Rodrı́guez-Franco, M. I. (2014) · Journal of Medicinal Chemistry · doi:10.1021/jm5000613 · Cited by 90 · see citing works

Discovery of a Phosphodiesterase 9A Inhibitor as a Potential Hypoglycemic Agent

Shao, Y., Huang, M., Cui, W., Feng, L.-J., Wu, Y., Cai, Y.-H., Li, Z., Zhu, X., Liu, P., Wan, Y., et al. (2014) · Journal of Medicinal Chemistry · doi:10.1021/jm500836h · Cited by 74 · see citing works

Discovery of a Neuroprotective Chemical, ( S )- N -(3-(3,6-Dibromo-9 H -carbazol-9-yl)-2-fluoropropyl)-6-methoxypyridin-2-amine [(−)-P7C3-S243], with Improved Druglike Properties

Naidoo, J., Jesús‐Cortés, H. D., Huntington, P. J., Estill, S. J., Morlock, L., Starwalt, R., Mangano, T. J., Williams, N. S., Pieper, A. A., & Ready, J. M. (2014) · Journal of Medicinal Chemistry · doi:10.1021/jm401919s · Cited by 73 · see citing works

A rationally designed small molecule for identifying an in vivo link between metal–amyloid-β complexes and the pathogenesis of Alzheimer's disease

Beck, M. W., Oh, S. B., Kerr, R. A., Lee, H. J., Kim, S., Kim, S., Jang, M., Ruotolo, B. T., Lee, J., & Lim, M. H. (2015) · Chemical Science · doi:10.1039/c4sc03239j · Cited by 71 · see citing works

A Redox-Active, Compact Molecule for Cross-Linking Amyloidogenic Peptides into Nontoxic, Off-Pathway Aggregates: In Vitro and In Vivo Efficacy and Molecular Mechanisms

Derrick, J. S., Kerr, R. A., Nam, Y., Oh, S. B., Lee, H. J., Earnest, K. G., Suh, N., Peck, K. L., Özbil, M., Korshavn, K. J., et al. (2015) · Journal of the American Chemical Society · doi:10.1021/jacs.5b10043 · Cited by 70 · see citing works

Novel Levetiracetam Derivatives That Are Effective against the Alzheimer-like Phenotype in Mice: Synthesis, in Vitro, ex Vivo, and in Vivo Efficacy Studies

Sola, I., Aso, E., Frattini, D., López‐González, I., Espargaró, A., Sabaté, R., Pietro, O. D., Luque, F. J., Clos, M. V., Ferrer, I., et al. (2015) · Journal of Medicinal Chemistry · doi:10.1021/acs.jmedchem.5b00624 · Cited by 66 · see citing works

Interaction and reactivity of synthetic aminoisoflavones with metal-free and metal-associated amyloid-β

DeToma, A. S., Krishnamoorthy, J., Nam, Y., Lee, H. J., Brender, J., Kochi, A., Lee, D., Onnis, V., Congiu, C., Manfredini, S., et al. (2014) · Chemical Science · doi:10.1039/c4sc01531b · Cited by 58 · see citing works

Blood–brain barrier permeable anticholinesterase aurones: Synthesis, structure–activity relationship, and drug-like properties

Liew, K.-F., Chan, K., & Lee, C. Y. (2015) · European Journal of Medicinal Chemistry · doi:10.1016/j.ejmech.2015.02.055 · Cited by 54 · see citing works

Selective Nucleoside Triphosphate Diphosphohydrolase-2 (NTPDase2) Inhibitors: Nucleotide Mimetics Derived from Uridine-5′-carboxamide

Brunschweiger, A., Iqbal, J., Umbach, F., Scheiff, A. B., Munkonda, M. N., Sévigny, J., Knowles, A. F., & Müller, C. E. (2008) · Journal of Medicinal Chemistry · doi:10.1021/jm800175e · Cited by 52 · see citing works

Stemistry: the control of stem cells in situ using chemistry.

Davies, S., Kennewell, P., Russell, A., Seden, P. T., Westwood, R., & Wynne, G. (2015) · Journal of Medicinal Chemistry · doi:10.1021/jm500838d · Cited by 31 · see citing works

Elucidating the 3D structures of Al( iii )–Aβ complexes: a template free strategy based on the pre-organization hypothesis

Mujika, J. I., Rodrı́guez-Guerra, J., López, X., Ugalde, J. M., Rodrı́guez-Santiago, L., Sodupe, M., & Maréchal, J. (2017) · Chemical Science · doi:10.1039/c7sc01296a · Cited by 22 · see citing works

Computer-assisted designed “selenoxy–chinolin”: a new catalytic mechanism of the GPx-like cycle and inhibition of metal-free and metal-associated Aβ aggregation

Wang, Z., Wang, Y., Li, W., Liu, Z., Luo, Z., Sun, Y., Wu, R., Huang, L., & Li, X. (2015) · Dalton Transactions · doi:10.1039/c5dt02130h · Cited by 19 · see citing works

Activation of mitogen-activated protein kinase pathways during the death of PC12 cells is dependent on the state of differentiation

Lambeng, N., Willaime‐Morawek, S., Mariani, J., Ruberg, M., & Brugg, B. (2003) · Molecular Brain Research · doi:10.1016/s0169-328x(02)00669-1 · Cited by 17 · see citing works

Chelation-induced diradical formation as an approach to modulation of the amyloid-β aggregation pathway

Porter, M. R., Kochi, A., Karty, J. A., Lim, M. H., & Zaleski, J. M. (2014) · Chemical Science · doi:10.1039/c4sc01979b · Cited by 16 · see citing works

A newly designed molecule J2326 for Alzheimer's disease disaggregates amyloid fibrils and induces neurite outgrowth

Chang, P., Talekar, R. S., Kung, F., Chern, T., Huang, C., Ye, Q.-Q., Yang, M.-Y., Yu, C., Lai, S., Deore, R. R., et al. (2015) · Neuropharmacology · doi:10.1016/j.neuropharm.2015.01.004 · Cited by 15 · see citing works

Development of Multifunctional Molecules as Potential Therapeutic Candidates for Alzheimer’s Disease, Parkinson’s Disease, and Amyotrophic Lateral Sclerosis in the Last Decade

Savelieff, M. G., Nam, G., Kang, J., Lee, H. J., Lee, M., & Lim, M. H. (2018) · Chemical Reviews · doi:10.1021/acs.chemrev.8b00138 · Cited by 603 · see citing works

Quinoline and quinolone dimers and their biological activities: An overview

Chu, X., Wang, C., Liu, W., Liang, L., Gong, K., Zhao, C., & Sun, K. (2018) · European Journal of Medicinal Chemistry · doi:10.1016/j.ejmech.2018.10.035 · Cited by 249 · see citing works

Biological Effects of Quinolones: A Family of Broad-Spectrum Antimicrobial Agents

Millanao, A. R., Mora, A. Y., Villagra, N. A., Bucarey, S. A., & Hidalgo, A. A. (2021) · Molecules · doi:10.3390/molecules26237153 · Cited by 230 · see citing works

Multi-target design strategies for the improved treatment of Alzheimer's disease

Zhang, P., Xu, S., Zhu, Z., & Xu, J. (2019) · European Journal of Medicinal Chemistry · doi:10.1016/j.ejmech.2019.05.020 · Cited by 218 · see citing works

From combinations to multitarget-directed ligands: A continuum in Alzheimer’s disease polypharmacology

Albertini, C., Salerno, A., de Sena Murteira Pinheiro, P., & Bolognesi, M. L. (2021) · Medicinal Research Reviews · doi:10.1002/med.21699 · Cited by 179 · see citing works

Insights of 8-hydroxyquinolines: A novel target in medicinal chemistry

Gupta, R., Luxami, V., & Paul, K. (2021) · Bioorganic Chemistry · doi:10.1016/j.bioorg.2021.104633 · Cited by 159 · see citing works

Recent advances in the synthetic and medicinal perspective of quinolones: A review

Dhiman, P., Arora, N. R., Thanikachalam, P. V., & Monga, V. (2019) · Bioorganic Chemistry · doi:10.1016/j.bioorg.2019.103291 · Cited by 153 · see citing works

Alzheimer's disease: Updated multi-targets therapeutics are in clinical and in progress

Sang, Z., Wang, K., Dong, J., & Tang, L. (2022) · European Journal of Medicinal Chemistry · doi:10.1016/j.ejmech.2022.114464 · Cited by 127 · see citing works

Multitarget Therapeutic Strategies for Alzheimer’s Disease: Review on Emerging Target Combinations

Maramai, S., Benchekroun, M., Gabr, M. T., & Yahiaoui, S. (2020) · BioMed Research International · doi:10.1155/2020/5120230 · Cited by 121 · see citing works

Apigenin-rivastigmine hybrids as multi-target-directed liagnds for the treatment of Alzheimer’s disease

Sang, Z., Wang, K., Shi, J., Cheng, X., Zhu, G., Wei, R., Ma, Q., Yu, L., Zhao, Y., Tan, Z., et al. (2019) · European Journal of Medicinal Chemistry · doi:10.1016/j.ejmech.2019.111958 · Cited by 101 · see citing works

Recent Advances in the Synthesis and Biological Activity of 8-Hydroxyquinolines

Saadeh, H. A., Sweidan, K., & Mubarak, M. S. (2020) · Molecules · doi:10.3390/molecules25184321 · Cited by 96 · see citing works

The development of advanced structural framework as multi-target-directed ligands for the treatment of Alzheimer’s disease

Sang, Z., Wang, K., Shi, J., Liu, W., Cheng, X., Zhu, G., Wang, Y., Zhao, Y., Qiao, Z., Wu, A., et al. (2020) · European Journal of Medicinal Chemistry · doi:10.1016/j.ejmech.2020.112180 · Cited by 77 · see citing works

Recent Developments in Metal-Based Drugs and Chelating Agents for Neurodegenerative Diseases Treatments

Sales, T. A., Prandi, I. G., de Castro, A. A., Leal, D. H. S., da Cunha, E. F. F., Kuča, K., & Ramalho, T. C. (2019) · International Journal of Molecular Sciences · doi:10.3390/ijms20081829 · Cited by 73 · see citing works

Redox-Active Metal Ions and Amyloid-Degrading Enzymes in Alzheimer’s Disease

Kim, N., & Lee, H. J. (2021) · International Journal of Molecular Sciences · doi:10.3390/ijms22147697 · Cited by 67 · see citing works

Donepezil-butylated hydroxytoluene (BHT) hybrids as Anti-Alzheimer's disease agents with cholinergic, antioxidant, and neuroprotective properties

Cai, P., Fang, S., Yang, H., Yang, X., Liu, Q., Kong, L., & Wang, X. (2018) · European Journal of Medicinal Chemistry · doi:10.1016/j.ejmech.2018.08.005 · Cited by 59 · see citing works

Design, synthesis and anti-Alzheimer's disease activity study of xanthone derivatives based on multi-target strategy

Kou, X., Song, L., Wang, Y., Yu, Q., Ju, H., Yang, A., & Shen, R. (2019) · Bioorganic & Medicinal Chemistry Letters · doi:10.1016/j.bmcl.2019.126927 · Cited by 59 · see citing works

Current Pharmaceutical Aspects of Synthetic Quinoline Derivatives

Tabassum, R., Ashfaq, M. H., & Oku, H. (2020) · Mini-Reviews in Medicinal Chemistry · doi:10.2174/1389557520999201214234735 · Cited by 53 · see citing works

ROS-responsive and multifunctional anti-Alzheimer prodrugs: Tacrine-ibuprofen hybrids via a phenyl boronate linker

Liu, Z., Zhang, B., Xia, S., Fang, L., & Gou, S.-H. (2020) · European Journal of Medicinal Chemistry · doi:10.1016/j.ejmech.2020.112997 · Cited by 48 · see citing works

A novel class of multitarget anti-Alzheimer benzohomoadamantane‒chlorotacrine hybrids modulating cholinesterases and glutamate NMDA receptors

Pérez-Areales, F. J., Turcu, A. L., Barniol‐Xicota, M., Pont, C., Pivetta, D., Espargaró, A., Bartolini, M., Simone, A. D., Andrisano, V., Pérez, B., et al. (2019) · European Journal of Medicinal Chemistry · doi:10.1016/j.ejmech.2019.07.051 · Cited by 43 · see citing works

Centrally Active Multitarget Anti-Alzheimer Agents Derived from the Antioxidant Lead CR-6

Pérez-Areales, F. J., Garrido, M., Aso, E., Bartolini, M., Simone, A. D., Espargaró, A., Ginex, T., Sabaté, R., Pérez, B., Andrisano, V., et al. (2020) · Journal of Medicinal Chemistry · doi:10.1021/acs.jmedchem.0c00528 · Cited by 43 · see citing works

Design, synthesis and biological evaluation of naringenin carbamate derivatives as potential multifunctional agents for the treatment of Alzheimer’s disease

Wu, J., Kou, X., Ju, H., Zhang, H., Yang, A., & Shen, R. (2021) · Bioorganic & Medicinal Chemistry Letters · doi:10.1016/j.bmcl.2021.128316 · Cited by 42 · see citing works

Design, synthesis, and evaluation of isoflavone analogs as multifunctional agents for the treatment of Alzheimer's disease

Wang, D., Hu, M. S., Li, X., Zhang, D., Chen, C., Fu, J., Shao, S., Shi, G., Zhou, Y., Wu, S., et al. (2019) · European Journal of Medicinal Chemistry · doi:10.1016/j.ejmech.2019.02.053 · Cited by 41 · see citing works

Selenepezil, a Selenium-Containing Compound, Exerts Neuroprotective Effect via Modulation of the Keap1–Nrf2–ARE Pathway and Attenuates Aβ-Induced Cognitive Impairment in Vivo

Yan, J., Pang, Y., Zhuang, J., Lin, H., Zhang, Q., Han, L., Ke, P., Zhuang, J., & Huang, X. (2019) · ACS Chemical Neuroscience · doi:10.1021/acschemneuro.9b00106 · Cited by 40 · see citing works

Design, synthesis, and biological evaluation of diosgenin-indole derivatives as dual-functional agents for the treatment of Alzheimer’s disease

Zhou, L., Liang, Y.-F., Huang, Y., Yang, G., Zheng, L., Sun, J., Li, Y., Zhu, F., Qian, H., Wang, R., et al. (2021) · European Journal of Medicinal Chemistry · doi:10.1016/j.ejmech.2021.113426 · Cited by 39 · see citing works

Design, synthesis and evaluation of quinoline- O -carbamate derivatives as multifunctional agents for the treatment of Alzheimer’s disease

Chen, H., Mi, J., Li, S., Liu, Z., Yang, J. L., Chen, R., Wang, Y., Ban, Y., Zhou, Y. M., Dong, W., et al. (2023) · Journal of Enzyme Inhibition and Medicinal Chemistry · doi:10.1080/14756366.2023.2169682 · Cited by 36 · see citing works

Quinoline Quest: Kynurenic Acid Strategies for Next-Generation Therapeutics via Rational Drug Design

Tanaka, M., Szatmári, I., & Vécsei, L. (2025) · Pharmaceuticals · doi:10.3390/ph18050607 · Cited by 35 · see citing works

Importance of Biometals as Targets in Medicinal Chemistry: An Overview about the Role of Zinc (II) Chelating Agents

Leuci, R., Brunetti, L., Laghezza, A., Loiodice, F., Tortorella, P., & Piemontese, L. (2020) · Applied Sciences · doi:10.3390/app10124118 · Cited by 35 · see citing works

Metals and Metal-Nanoparticles in Human Pathologies: From Exposure to Therapy

Lachowicz, J. I., Lecca, L. I., Meloni, F., & Campagna, M. (2021) · Molecules · doi:10.3390/molecules26216639 · Cited by 34 · see citing works

Design, Synthesis, and Biological Evaluation of Dual-Target Inhibitors of Acetylcholinesterase (AChE) and Phosphodiesterase 9A (PDE9A) for the Treatment of Alzheimer’s Disease

Hu, J., Huang, Y.-D., Pan, T., Zhang, T., Su, T., Li, X., Luo, H., & Huang, L. (2018) · ACS Chemical Neuroscience · doi:10.1021/acschemneuro.8b00376 · Cited by 33 · see citing works

Design, synthesis and biological evaluation of novel carboline-cinnamic acid hybrids as multifunctional agents for treatment of Alzheimer’s disease

Liao, Q., Li, Q., Zhao, Y., Jiang, P. H., Yan, Y., Sun, H., Liu, W., Feng, F., & Qu, W. (2020) · Bioorganic Chemistry · doi:10.1016/j.bioorg.2020.103844 · Cited by 33 · see citing works

Innovative approaches to Alzheimer's therapy: Harnessing the power of heterocycles, oxidative stress management, and nanomaterial drug delivery system

Umar, M., Rehman, Y., Ambreen, S., Mumtaz, S. M., Shaququzzaman, M., Alam, M. M., & Ali, R. (2024) · Ageing Research Reviews · doi:10.1016/j.arr.2024.102298 · Cited by 31 · see citing works

Discovery of novel butyrylcholinesterase inhibitors for treating Alzheimer's disease

Sang, Z., Huang, S., Tan, W., Ban, Y., Wang, K., Fan, Y., Chen, H., Zhang, Q., Liang, C., Mi, J., et al. (2025) · Acta Pharmaceutica Sinica B · doi:10.1016/j.apsb.2025.02.030 · Cited by 30 · see citing works

SAR studies of quinoline and derivatives as potential treatments for Alzheimer’s disease

Li, Z., Yin, L., Zhao, D., Jin, L., Sun, Y.-J., & Tan, C. (2022) · Arabian Journal of Chemistry · doi:10.1016/j.arabjc.2022.104502 · Cited by 29 · see citing works

Discovery of Selective Butyrylcholinesterase (BChE) Inhibitors through a Combination of Computational Studies and Biological Evaluations

Zhou, Y., Lü, X., Yang, H., Chen, Y., Wang, F., Li, J., Tang, Z., Cheng, X.-F., Yang, Y., Xu, L., et al. (2019) · Molecules · doi:10.3390/molecules24234217 · Cited by 27 · see citing works

A Review on Synthesis and Biological Applications of Quinoline Derivative as Fused Aromatic Compounds

Mohasin, M., Alam, M. Z., Ullah, Q., Ahmad, A., Rahaman, P. F., & Khan, S. A. (2023) · Polycyclic aromatic compounds · doi:10.1080/10406638.2023.2270118 · Cited by 26 · see citing works

Assessing indole derivative molecules as dual acetylcholinesterase and butyrylcholinesterase inhibitors through In Vitro inhibition and molecular modelling studies

Alım, Z., Şirinzade, H., Kılınç, N., Dilek, E., & Süzen, S. (2024) · Journal of Molecular Structure · doi:10.1016/j.molstruc.2024.138276 · Cited by 26 · see citing works

DFIQ, a Novel Quinoline Derivative, Shows Anticancer Potential by Inducing Apoptosis and Autophagy in NSCLC Cell and In Vivo Zebrafish Xenograft Models

Huang, H., Bow, Y., Wang, C., Chen, Y., Fu, P.-R., Chang, K.-F., Wang, T.-W., Tseng, C.-H., Chen, Y., & Chiu, C. (2020) · Cancers · doi:10.3390/cancers12051348 · Cited by 26 · see citing works

Recent Progress of Bioactivities, Mechanisms of Action, Total Synthesis, Structural Modifications and Structure-activity Relationships of Indole Derivatives: A Review

Xu, H., & Li, T.-Z. (2022) · Mini-Reviews in Medicinal Chemistry · doi:10.2174/1389557522666220330123538 · Cited by 26 · see citing works

Design, synthesis, and biological evaluation of histone deacetylase inhibitors possessing glutathione peroxidase-like and antioxidant activities against Alzheimer’s disease

Hu, J., An, B., Pan, T., Li, Z., Huang, L., & Li, X. (2018) · Bioorganic & Medicinal Chemistry · doi:10.1016/j.bmc.2018.10.022 · Cited by 26 · see citing works

Chemoselective Trimerization of Isocyanides: De Novo Synthesis of 2-Indole-Substituted Quinolines and Pyridines

Bao, L., Liu, Y., Peng, J., Wang, Y., Dong, J., & Xu, X. (2021) · Organic Letters · doi:10.1021/acs.orglett.1c03693 · Cited by 25 · see citing works

Structure-activity relationship studies of (E)-3,4-dihydroxystyryl alkyl sulfones as novel neuroprotective agents based on improved antioxidant, anti-inflammatory activities and BBB permeability

Chen, Y., Wu, B., Hao, Y., Liu, Y., Zhang, Z., Tian, C., Ning, X., Guo, Y. Q., Liu, J., & Wang, X. (2019) · European Journal of Medicinal Chemistry · doi:10.1016/j.ejmech.2019.03.044 · Cited by 21 · see citing works

Antioxidants in anti‐Alzheimer's disease drug discovery

Guo, J., Zhu, Y., Zhi, J., Lou, Q., Bai, R., & He, Y. (2025) · Ageing Research Reviews · doi:10.1016/j.arr.2025.102707 · Cited by 20 · see citing works

Design, Synthesis, and Biological Evaluation of Ferulic Acid-Piperazine Derivatives Targeting Pathological Hallmarks of Alzheimer’s Disease

Singh, G., Kumar, S., Panda, S. R., Kumar, P., Rai, S., Verma, H., Singh, Y. P., Kumar, S., Srikrishna, S., Naidu, V. G. M., et al. (2024) · ACS Chemical Neuroscience · doi:10.1021/acschemneuro.4c00130 · Cited by 19 · see citing works

Design and Synthesis of Novel Tacrine–Indole Hybrids As Potential Multitarget-Directed Ligands for the Treatment of Alzheimer's Disease

Hamuľaková, S., Kudlicková, Z., Janovec, L., Mezencev, R., Deckner, Z. J., Chernoff, Y. O., Janočková, J., Ihnatova, V., Bzonek, P., Novakova, N., et al. (2021) · Future Medicinal Chemistry · doi:10.4155/fmc-2020-0184 · Cited by 19 · see citing works

From virtual screening hits targeting a cryptic pocket in BACE-1 to a nontoxic brain permeable multitarget anti-Alzheimer lead with disease-modifying and cognition-enhancing effects.

Pont, C., Ginex, T., Griñán-Ferré, C., Scheiner, M., Mattellone, A., Martínez, N., Arce, E., Soriano-Fernández, Y., Naldi, M., Simone, A. D., et al. (2021) · European journal of medicinal chemistry · doi:10.1016/j.ejmech.2021.113779 · Cited by 17 · see citing works

DPPH and nitric oxide free radical scavenging potential of phenyl quinoline derivatives and their transition metal complexes

Tabassum, R., Ashfaq, M. H., Tahir, T., & Oku, H. (2022) · Journal of Molecular Structure · doi:10.1016/j.molstruc.2022.134058 · Cited by 18 · see citing works

Nanotechnology‐empowered therapeutics targeting neurodegenerative diseases

Wang, Z., Gonzalez, K. M., Cordova, L. E., & Lu, J. (2023) · Wiley Interdisciplinary Reviews Nanomedicine and Nanobiotechnology · doi:10.1002/wnan.1907 · Cited by 18 · see citing works

Recent Advancements in the Treatment of Alzheimer’s Disease: A Multitarget-directed Ligand Approach

Kumar, S., Mahajan, A. T., Ambatwar, R., & Khatik, G. L. (2023) · Current Medicinal Chemistry · doi:10.2174/0109298673264076230921065945 · Cited by 17 · see citing works

Dimerization–cyclization reactions of isocyanoaryl-tethered alkylidenecyclobutanes via a triplet biradical mediated process

Tao, L., Wei, Y., & Shi, M. J. (2020) · Organic Chemistry Frontiers · doi:10.1039/d0qo00878h · Cited by 15 · see citing works

A Review on the Recent Progress of Layered Double Hydroxides (LDHs)-based Catalysts for Heterocyclic Synthesis

Farouki, K. E., Kacem, M., Dib, M., Ouchetto, H., Hafid, A., & Khouili, M. (2023) · Current Organocatalysis · doi:10.2174/0122133372264682231019101634 · Cited by 15 · see citing works

Discovery of a promising agent IQZ23 for the treatment of obesity and related metabolic disorders

Rao, Y., Zhao, X. D., Hu, Y., Li, C., Xu, Y., Song, Q., Yu, H., Song, B.-B., Chen, S.-B., Li, Q., et al. (2020) · European Journal of Medicinal Chemistry · doi:10.1016/j.ejmech.2020.112172 · Cited by 15 · see citing works

WBQ5187, a Multitarget Directed Agent, Ameliorates Cognitive Impairment in a Transgenic Mouse Model of Alzheimer’s Disease and Modulates Cerebral β-Amyloid, Gliosis, cAMP Levels, and Neurodegeneration

Wang, Z., Cao, M., Xiang, H., Wang, W., Feng, X., & Yang, X. (2019) · ACS Chemical Neuroscience · doi:10.1021/acschemneuro.9b00409 · Cited by 14 · see citing works

Steroid–Quinoline Hybrids for Disruption and Reversion of Protein Aggregation Processes

Albuquerque, H. M. T., da Silva, R. N., Pereira, M., Maia, A. F., Guieu, S., Soares, A. R., Santos, C. M. M., Vieira, S. I., & Silva, A. M. S. (2022) · ACS Medicinal Chemistry Letters · doi:10.1021/acsmedchemlett.1c00604 · Cited by 14 · see citing works

Novel Multi-Target Agents Based on the Privileged Structure of 4-Hydroxy-2-quinolinone

Kostopoulou, I., Tzani, A., Chronaki, K., Prousis, K. C., Pontiki, E. A., Hadjipavlou‐Litina, D., & Detsi, A. (2023) · Molecules · doi:10.3390/molecules29010190 · Cited by 12 · see citing works

Recent Advances in Transition Metal Free Synthetic Protocols for Quinoline Derivatives

Tabassum, R., Ashfaq, M. H., & Oku, H. (2020) · Current Organic Chemistry · doi:10.2174/1385272824999200616122557 · Cited by 12 · see citing works

Recent Progress in the Drug Development for the Treatment of Alzheimer’s Disease Especially on Inhibition of Amyloid-peptide Aggregation

Liu, Y., Cong, L., Han, C., Li, B., & Dai, R. (2020) · Mini-Reviews in Medicinal Chemistry · doi:10.2174/1389557520666201127104539 · Cited by 10 · see citing works

Investigation of new 1,2,3-triazolyl-quinolinyl-propan-2-ol derivatives as potential antimicrobial agents: in vitro and in silico approach

Shinde, A. D., Nandurkar, Y. M., Bhalekar, S., Walunj, Y., Ugale, S. R., Ahmad, I., Patel, H., Chavan, A., & Mhaske, P. C. (2023) · Journal of Biomolecular Structure and Dynamics · doi:10.1080/07391102.2023.2217922 · Cited by 8 · see citing works

Fluorescent sterol probes for intracellular transport, imaging, and therapeutics

Mansuri, S., Mukherjee, T., & Kanvah, S. (2022) · Current Opinion in Chemical Biology · doi:10.1016/j.cbpa.2022.102222 · Cited by 7 · see citing works

Rapid discovery and crystallography study of highly potent and selective butylcholinesterase inhibitors based on oxime-containing libraries and conformational restriction strategies

Jing, L., Wei, W., Meng, B., Chantegreil, F., Nachon, F., Martı́nez, A., Wu, G., Zhao, H., Song, Y., Kang, D., et al. (2023) · Bioorganic Chemistry · doi:10.1016/j.bioorg.2023.106465 · Cited by 7 · see citing works

Effect of a newly synthesized quinoline-based compound (PPQ-8) on murine schistosomiasis mansoni

Taman, A. I., Alhusseiny, S. M., Saleh, N. E., Youssef, M., Mansour, B., Massoud, M. A. M., & El-Beshbishi, S. N. (2020) · Journal of Helminthology · doi:10.1017/s0022149x2000005x · Cited by 7 · see citing works

Comprehensive methodologies for synthesizing tricyclic fused pyrimidoquinolines of biological relevance: a review

Mekheimer, R. A., Allam, S. M. R., Al‐Sheikh, M. A., Medrasi, H. Y., Abd‐Elmonem, M., & Sadek, K. U. (2025) · RSC Advances · doi:10.1039/d5ra00779h · Cited by 6 · see citing works

Mechanistic Insights into Tf2O-Promoted Electrophilic Activation of 2-Propynamides and a New Synthesis of 2,4-Disubstituted Quinolines

Shan, L., Li, H., Zheng, W., Wang, X., Wang, X., & Hu, Y. (2022) · Organic Letters · doi:10.1021/acs.orglett.2c03565 · Cited by 6 · see citing works

Wolfberry extracts inhibit Aβ1-42 aggregation and rescue memory loss of AD drosophila

Li, C., & Yang, J. (2019) · Food Science and Human Wellness · doi:10.1016/j.fshw.2019.12.007 · Cited by 6 · see citing works

Reactions of Quinolinecarbaldehydes with Arenes under Superelectrophilic Activation. NMR and DFT Studies of Dicationic Electrophilic Species

Borisova, M. A., Ryabukhin, D. S., Ivanov, A. Y., Boyarskaya, I. А., Spiridonova, D. V., Kompanets, M. O., & Vasilyev, A. V. (2021) · Chemistry of Heterocyclic Compounds · doi:10.1007/s10593-021-03015-0 · Cited by 6 · see citing works

Comprehensive safety evaluation of a novel multitargeting compound XYY-CP1106: A candidate for Alzheimer's disease

Fan, M., Song, X., Lu, L., He, J., Shen, Y., Zhang, C., Wang, F., & Xie, Y. (2024) · Biomedicine & Pharmacotherapy · doi:10.1016/j.biopha.2024.116786 · Cited by 5 · see citing works

Design, Synthesis, and Evaluation of New Hybrid Derivatives of 5,6-Dihydro-4H-pyrrolo[3,2,1-ij]quinolin-2(1H)-one as Potential Dual Inhibitors of Blood Coagulation Factors Xa and XIa

Skoptsova, A. A., Geronikaki, A. A., Novichikhina, N. P., Sulimov, A. V., Ilin, I. S., Sulimov, V. B., Bykov, G. A., Podoplelova, N. A., Pyankov, O. V., & Shikhaliev, K. S. (2024) · Molecules · doi:10.3390/molecules29020373 · Cited by 5 · see citing works

Discovery of novel melatonin–mydroxyquinoline hybrids as multitarget strategies for Alzheimer’s disease therapy

Wang, W., Pan, T., Su, R., Chen, M., Xiong, W., Xu, C., & Huang, L. (2024) · Frontiers in Chemistry · doi:10.3389/fchem.2024.1374930 · Cited by 5 · see citing works

Development of an efficient, one‐pot, multicomponent protocol for synthesis of 8‐hydroxy‐4‐phenyl‐1,2‐dihydroquinoline derivatives

Tabassum, R., Ashfaq, M. H., & Oku, H. (2020) · Journal of Heterocyclic Chemistry · doi:10.1002/jhet.4193 · Cited by 5 · see citing works

8-Hydroxyquinoline Derivatives as Drug Candidates for the Treatment of Alzheimer's Disease

Bartolomeu, P. F., Fortes, I. S., Zimmer, A. R., Lopes, M. S., & de Andrade, S. F. (2025) · Current Medicinal Chemistry · doi:10.2174/0109298673409645250823055140 · Cited by 4 · see citing works

Microwave assisted synthesis of new quinolone and coumarin molecular hybrids: SAR, molecular modelling studies as dual antagonists and its antimicrobial evaluation targeting bacterial and fungal infections

Viveka, T. L., Angajala, G., Aruna, V., Nakka, M., & Aparna, Y. (2024) · Journal of Molecular Structure · doi:10.1016/j.molstruc.2024.137482 · Cited by 4 · see citing works

Mechanistic aspects of binding of telomeric over parallel G ‐quadruplex with novel synthesized Knoevenagel condensate 4‐nitrobenzylidene curcumin

Sharma, P., & Jha, N. S. (2023) · Journal of Molecular Recognition · doi:10.1002/jmr.3041 · Cited by 4 · see citing works

QCTA-1, a quinoline derivative, ameliorates pentylenetetrazole-induced kindling and memory comorbidity in mice: Involvement of antioxidant system of brain.

Vogt, A. G., de Oliveira, R. L., Voss, G. T., Blödorn, G. B., Alves, D. A. C., Wilhelm, E. A., & Luchese, C. (2022) · Pharmacology Biochemistry and Behavior · doi:10.1016/j.pbb.2022.173357 · Cited by 4 · see citing works

Construction of novel penta cyclic indolo-furo[3,2-c]quinoline and dihydrochromeno-furo[2,3-b]indol via sequential annulation strategy

Yadav, M. B., & Jeong, Y. T. (2022) · Tetrahedron Letters · doi:10.1016/j.tetlet.2022.154158 · Cited by 4 · see citing works

7-Hydroxy-4-phenyl-1, 2-dihydroquinoline derivatives: synthesis via one-pot, three-component reaction and structure elucidation

Tabassum, R., Ashfaq, M. H., & Oku, H. (2020) · Heliyon · doi:10.1016/j.heliyon.2020.e05035 · Cited by 4 · see citing works

A turn on fluorescent probe for Zn2+ based on Quinoline with flexible chelating group

Zheng, D., Huang, R., & Lan, H. (2025) · Results in Chemistry · doi:10.1016/j.rechem.2025.102523 · Cited by 3 · see citing works

Recent Advances in the Quest for Treatment and Management of Alzheimer and Other Dementia

Tanwir, S. E., & Kumar, A. (2019) · Open Journal of Medicinal Chemistry · doi:10.4236/ojmc.2019.91001 · Cited by 3 · see citing works

Discovery of small molecules for the treatment of Alzheimer’s disease

Rao, P. P. N., Pham, A. T., & Shakeri, A. (2020) · Elsevier eBooks · doi:10.1016/b978-0-12-818349-6.00011-x · Cited by 3 · see citing works

Synthesis and Activity of Miconazole Derivatives as Dual BChE/IDO1 Inhibitors for the Treatment of Alzheimer's Disease

Lü, X., Liu, Y., Qin, N., Yang, H., Qiao, Y., Jiang, X., Chen, Y., Feng, F., Liu, W., Zhou, Y., et al. (2021) · Future Medicinal Chemistry · doi:10.4155/fmc-2021-0039 · Cited by 3 · see citing works

Reductive Cyclization of 2‐Nitro‐ and β‐Nitrostyrenes, 2‐Nitrobiphenyls, and 1‐Nitro‐1,3‐Dienes to Indoles, Carbazoles, and Pyrroles

Söderberg, B. C. G., & Berkowitz, W. F. (2022) · Organic reactions · doi:10.1002/0471264180.or111.02 · Cited by 3 · see citing works

8-Hydroxyquinolines: A Promising Pharmacophore Potentially Developed as Disease-Modifying Agents for Neurodegenerative Diseases: A Review

Prachayasittikul, V., Pingaew, R., Prachayasittikul, S., & Prachayasittikul, V. (2022) · Heterocycles · doi:10.3987/rev-22-sr(r)6 · Cited by 2 · see citing works

Crystal structure, theoretical studies, and biological assessment of Co(II) and Cd(II) complexes of quinoline-based ligands: Direct coordination versus ligand hydrolysis

Fathalla, E. M., El‐Faham, A., Soliman, S. M., Barakat, A., Haukka, M., Ramadan, S., Abu-Youssef, M. A. M., M.A.Badr, A., & Yousri, A. (2026) · Inorganica Chimica Acta · doi:10.1016/j.ica.2026.123269 · Cited by 1 · see citing works

Unveiling the pathogenesis and therapeutic strategies of Alzheimer’s disease through cuproptosis

Xu, S., Mu, J., Wang, Z., Yang, J., Tian, D., Shi, T., Lan, J., He, P., Hao, Z., Fu, Y., et al. (2026) · BioMetals · doi:10.1007/s10534-026-00835-5 · Cited by 1 · see citing works

Alzheimer's disease therapeutics

Sang, Z., & Huang, L. (2023) · Elsevier eBooks · doi:10.1016/b978-0-443-18611-0.00031-0 · Cited by 1 · see citing works

Funcionalização regiosseletiva de cloroquinolinas visando a síntese de compostos de interesse medicinal

Murie, V. E. (2020) · doi:10.11606/t.60.2020.tde-22092021-090511

Base-promoted tandem synthesis of 2-azaaryl indoline

Chen, S., Tan, J., Wu, H., Zhao, Q., & Shang, Y. (2023) · Organic & Biomolecular Chemistry · doi:10.1039/d3ob01444d

A Brief Review of the Medicinally Important Indole Derivatives

Dube, P. N., Chaudhari, S., Thakare, P. Y., Yadav, S., & Kore, Y. S. (2023) · Journal Of Advanced Zoology · doi:10.53555/jaz.v44is7.3027

Copper‐Catalyzed Synthesis of Benzofuro[3,2‐b]Indole Frame Work via Intramolecular Oxidative C−H Bond Amination

Edukondalu, P., Ravi, N., Matta, R., Kishan, G., & Kumar, K. S. (2025) · Asian Journal of Organic Chemistry · doi:10.1002/ajoc.202400702

Indole-Derived Compounds as Redox-Modulators: Antioxidant Mechanisms in Neuronal Protection

Singh, A. A., Arukha, A. P., & Song, M. (2026) · Molecules · doi:10.3390/molecules31132323

Quinoline-indole hybrids as privileged scaffolds: Synthetic strategies, biological profiles and medicinal potential

Manahelohe, G. M., Li, C.-S., Shi, C.-X., Chen, X., Li, F., Wang, Y., Hao, G., & Zhang, M. (2026) · Advanced Agrochem · doi:10.1016/j.aac.2026.09.003

Acridinone-sulfonamide hybrids: synthesis, photophysical properties, DFT Analysis, insilico ADMET and antiviral docking against adenovirus

Shanmugavel, B., & Vijayakumar, V. (2026) · Scientific Reports · doi:10.1038/s41598-026-65282-1

Translating Molecular Pathogenesis into Therapeutics: Emerging Strategies and Clinical Prospects for Alzheimer’s Disease

Piplani, M., Thakur, S., Kumar, P., Garg, S. S., Goyal, A., & Goyal, P. (2026) · Biomedical & Pharmacology Journal · doi:10.13005/bpj/3483

BindingDB Entry 50015896: Alzheimer's disease: Updated multi-targets therapeutics are in clinical and in progress.

BindingDB (2023) · UC San Diego · doi:10.7270/q2fb56xk

BindingDB Entry 50003282: Donepezil-butylated hydroxytoluene (BHT) hybrids as Anti-Alzheimer's disease agents with cholinergic, antioxidant, and neuroprotective properties.

BindingDB (2020) · UC San Diego · doi:10.7270/q29p34c1

BindingDB Entry 50007137: Quinoline and quinolone dimers and their biological activities: An overview.

BindingDB (2021) · UC San Diego · doi:10.7270/q2g1643k

BindingDB Entry 50012776: Centrally Active Multitarget Anti-Alzheimer Agents Derived from the Antioxidant Lead CR-6.

BindingDB (2022) · UC San Diego · doi:10.7270/q23n2733

BindingDB Entry 50014696: From virtual screening hits targeting a cryptic pocket in BACE-1 to a nontoxic brain permeable multitarget anti-Alzheimer lead with disease-modifying and cognition-enhancing effects.

BindingDB (2022) · UC San Diego · doi:10.7270/q2tb1bqf

BindingDB Entry 50010493: Design, synthesis and anti-Alzheimer's disease activity study of xanthone derivatives based on multi-target strategy.

BindingDB (2021) · UC San Diego · doi:10.7270/q2sj1q5k

BindingDB Entry 50013266: The development of advanced structural framework as multi-target-directed ligands for the treatment of Alzheimer's disease.

BindingDB (2022) · UC San Diego · doi:10.7270/q2n301px

BindingDB Entry 50013055: ROS-responsive and multifunctional anti-Alzheimer prodrugs: Tacrine-ibuprofen hybrids via a phenyl boronate linker.

BindingDB (2022) · UC San Diego · doi:10.7270/q2np2848

BindingDB Entry 50014151: Design, synthesis and biological evaluation of naringenin carbamate derivatives as potential multifunctional agents for the treatment of Alzheimer's disease.

BindingDB (2022) · UC San Diego · doi:10.7270/q2p84gpv

Novel 8-hydroxyquinoline derivatives targeting β-amyloid aggregation, metal chelation and oxidative stress against Alzheimer’s disease

Yang, X., Cai, P., Liu, Q., Wu, J., Yin, Y., Wang, X., & Kong, L. (2018) · Bioorganic & Medicinal Chemistry · doi:10.1016/j.bmc.2018.04.043 · Cited by 69 · see citing works

Design, Synthesis, and Evaluation of Orally Available Clioquinol-Moracin M Hybrids as Multitarget-Directed Ligands for Cognitive Improvement in a Rat Model of Neurodegeneration in Alzheimer’s Disease

Wang, Z., Wang, Y., Wang, B., Li, W., Huang, L., & Li, X. (2015) · Journal of Medicinal Chemistry · doi:10.1021/acs.jmedchem.5b01222 · Cited by 120 · see citing works

Design, Synthesis, and Biological Investigation of Quinazoline Derivatives as Multitargeting Therapeutics in Alzheimer’s Disease Therapy

Verma, A., Waiker, D. K., Singh, N. D., Roy, A., Singh, N., Saraf, P., Bhardwaj, B., Krishnamurthy, S., Trigun, S. K., & Shrivastava, S. K. (2024) · ACS Chemical Neuroscience · doi:10.1021/acschemneuro.3c00653 · Cited by 24 · see citing works

Novel 8‐Hydroxyquinoline Derivatives as Multitarget Compounds for the Treatment of Alzheimer′s Disease

Prati, F., Bergamini, C., Fato, R., Soukup, O., Korábečný, J., Andrisano, V., Bartolini, M., & Bolognesi, M. L. (2016) · ChemMedChem · doi:10.1002/cmdc.201600014 · Cited by 91 · see citing works

Biological Evaluation of 8-Hydroxyquinolines as Multi-Target Directed Ligands for Treating Alzheimer’s Disease

Knez, D., Sosič, I., Pišlar, A. H., Mitrović, A., Jukič, M., Kos, J., & Gobec, S. (2019) · Current Alzheimer Research · doi:10.2174/1567205016666191010130351 · Cited by 11 · see citing works